Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -3.04M | -3.95M | -4.72M | -4.60M | -3.90M |
| Total Depreciation and Amortization | 230.60K | 274.90K | 322.50K | 364.60K | 401.90K |
| Total Amortization of Deferred Charges | 345.00K | 335.00K | 369.90K | 391.90K | 430.50K |
| Total Other Non-Cash Items | 76.70K | 121.40K | 383.30K | 442.10K | 645.10K |
| Change in Net Operating Assets | 1.11M | 2.10M | 2.59M | 2.80M | 3.20M |
| Cash from Operations | -1.28M | -1.12M | -1.06M | -605.00K | 780.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | -3.10K | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -3.10K | 0.00 |
| Total Debt Issued | 1.95M | 1.85M | 1.98M | 1.98M | 130.00K |
| Total Debt Repaid | -600.50K | -752.50K | -922.60K | -1.24M | -1.63M |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 240.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.35M | 1.10M | 1.06M | 738.80K | -1.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.80K | -20.00K | -3.80K | 130.60K | -480.00K |
